ALDOB and gastric cancer: Specifically, reduced ALDOB expression in gastric cancer tissues activates downstream glycolytic enzymes by lifting inhibition on the AKT signaling pathway, thereby promoting aerobic glycolysis, tumor growth, and metastasis.